# PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
> **ANDA207498** · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-06-28
## Drug
- **FDA Application Number:** ANDA207498
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
- **Generic name:** Ascorbic Acid
- **Active ingredients:** ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TARO
- **First approval:** 2024-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207498)
---
*MORVS · CC0 1.0*